We have launched our mobile app, get it now. Call : 9354229384, 9354252518, 9999830584.  

News in Short

Filter By Date

Filter By Date

Pfizer starts study of mRNA Flu vaccine

Date: 01 October 2021 Tags: Biotechnology
  • Pfizer Inc said has dosed the first patient in a trial testing a flu vaccine based on messenger RNA, the same technology used in the COVID-19 shots made by the U.S. drugmaker and BioNTech.
  • The early-stage trial, conducted in the United States, will test the vaccine in healthy adults ages 65- 85.
  • The study will test the safety and immune responses of the vaccine, compared to another FDA-approved influenza vaccine.